CV Outcomes

Interpreting Efficacy Results from Cardiovascular Outcomes Trials

Interpreting Efficacy Results from Cardiovascular Outcomes Trials

 

Interpreting Efficacy Results from Cardiovascular Outcomes Trials

The faculty for this program (short course) is Kevin C. Maki, PhD, Chief Scientist for Midwest Biomedical Research’s Center for Metabolic and Cardiovascular Health.  Dr. Maki specializes in the design and conduct of clinical studies in human nutrition, metabolism, and chronic disease risk factor management.  He holds Adjunct Faculty positions teaching Epidemiology and Biostatistics at the Illinois Institute of Technology and DePaul University, and has participated in more than 250 clinical trials and observational studies as an investigator, consultant, or statistician.

About the Course

Cardiovascular outcomes trials are integral to evidence-based cardiovascular medicine, and they are the most effective means for demonstrating that an intervention reduces major adverse cardiovascular events.  A sound understanding of the fundamentals of clinical study design and statistical methodology is essential for the interpretation of efficacy results from cardiovascular outcomes trials.  This webinar aims to deliver information for non-statistician research and health professionals about how to systematically evaluate and interpret results from cardiovascular outcomes trials.  The course will provide a review of the following concepts:

  • Comparing measures of cardiovascular event incidence between groups
    1. Relative risk
    2. Hazard ratio
    3. Odds ratio
  • Comparing event rates and treatment effects
    1. Relative risk reduction
    2. Absolute risk reduction
    3. Number needed to treat (or harm)
  • Pitfalls in making comparisons between cardiovascular outcomes trials, including the three key questions
    1. Who was treated (risk profile)?
    2. What outcomes were assessed?
    3. Over how long a period?
  • Additional factors to consider in the interpretation of findings from cardiovascular outcomes trials
    1. Evaluating the roles of chance, bias and confounding
    2. Factors affecting validity and generalizability
    3. Assessing the potential for type I and type II statistical errors

Who will benefit from this short course?

This course aims to provide research and health professionals with important information to aid in their interpretation of results from cardiovascular outcomes trials.  Persons working or studying in the following fields will benefit from this program:

  • Primary Care Physicians
  • Subspecialists (Cardiology, Endocrinology, etc.)
  • Nurse Practitioners
  • Physician Assistants
  • Clinical Research Professionals

What will you receive?

With your purchase of Interpreting Efficacy Results from Cardiovascular Outcomes Trials, or any of the short courses sold by MB Clinical Academy, you receive:

  • A PDF of the course slides
  • Narrated audio/video recordings of the presentations (mp4 files)

How much does it cost?

The cost of this program is normally $39.  For a limited time, we will be offering at an introductory price of $29.

Questions:

Questions about MB Clinical Academy programs can be directed to info@mbclinicalresearch.com.

Bring an MB Clinical Academy Speaker to Your Organization:

If you are part of an organization that would like to invite a speaker from MB Clinical Academy, please contact us at info@mbclinicalresearch.com or by telephone at 630-469-6600.

 

Diabetes

Diet and Prevention of Type 2 Diabetes Mellitus

Diet and Prevention of Type 2 Diabetes Mellitus

Diet and Prevention of Type 2 Diabetes:  Beyond Weight Loss and Exercise

The faculty for this program is Kevin C. Maki, PhD, Chief Scientist for the Midwest Biomedical Research Center for Metabolic and Cardiovascular Health.  Dr. Maki specializes in the design and conduct of clinical studies in human nutrition, metabolism, and chronic disease risk factor management.  He holds Adjunct Faculty positions teaching Epidemiology and Biostatistics at the Illinois Institute of Technology and DePaul University, and has participated in more than 250 clinical trials and observational studies as an investigator, consultant, or statistician.  Dr. Maki has been studying the relationships between diet and diabetes risk for more than 25 years.

About the Course

Type 2 diabetes mellitus is an enormous public health concern worldwide that affects nearly 30 million people in the United States alone.  Diet is a vital tool not only for managing diabetes, but also for preventing it.  This webinar aims to deliver important information for healthcare providers, dietitians and research scientists to improve their understanding of the relationships between dietary factors and diabetes risk.  The course will provide the latest scientific evidence on:

  • Module 1: Epidemiology and pathophysiology of type 2 diabetes mellitus (T2D)
  • Module 2: Predictors of T2D risk and effects of interventions on incidence
  • Module 3: Summary of the associations and mechanisms through which diet may
    affect type 2 diabetes risk, with an emphasis on insulin sensitivity and glycemic load

Who will benefit from this webinar?

This course aims to provide clinicians and research professionals with up-to-date information about the role of diet in the prevention of type 2 diabetes mellitus.  Persons working or studying in the following fields will benefit from this program:

  • Dietitians/Nutritionists
  • Nutrition Scientists
  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Diabetes Educators

What will you receive?

With your purchase of Diet and Prevention of Type 2 Diabetes Mellitus, or any of the short courses sold by MB Clinical Academy, you receive:

  • A PDF of the course slides
  • Narrated audio/video recordings of the presentations (mp4 files)

How much does it cost?

The cost of this program is normally $79.  For a limited time, we will be offering at an introductory price of $49.

Questions:

Questions about MB Clinical Academy programs can be directed to info@mbclinicalresearch.com.

Bring an MB Clinical Academy Speaker to Your Organization:

If you are part of an organization that would like to invite a speaker from MB Clinical Academy, please contact us at info@mbclinicalresearch.com or by telephone at 630-469-6600.